Lyora Therapeutics, Inc.LT
SEC Form D filing

Lyora Therapeutics, Inc.

Biotech · Seed · Regulation D 506(b) · MA · Filed March 8, 2025

Offering amount
$2.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
March 8, 2025
Signature date
CIK
0002058969

Summary

Lyora Therapeutics biotech with $2M offering at seed/series-a boundary.

Source

FormDFlow indexes public-disclosure data from SEC EDGAR. Nothing on this page is investment advice.